
COVID-19, the disease it causes, surfaced in late 2019, and now had become a full-blown crisis worldwide. Over fifty key countries had declared a national emergency to combat coronavirus. With cases spreading, and the epicentre of the outbreak shifting to Europe, North America, India and Latin America, life in these regions has been upended the way it had been in Asia earlier in the developing crisis. As the coronavirus pandemic has worsened, the entertainment industry has been upended along with most every other facet of life. As experts work toward a better understanding, the world shudders in fear of the unknown, a worry that has rocked global financial markets, leading to daily volatility in the U.S. stock markets.
According to this latest study, the 2020 growth of Procaine will have significant change from previous year. By the most conservative estimates of global Procaine market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. We give this scenario a XX% probability, where under the scenario the supply chain will start to recover and quarantines and travel bans will ease, over the Q2. Longer-term, the effect of COVID-19 will be felt throughout the year with some degree of harm done by the virus. Over the next five years the Procaine market will register a XX% CAGR in terms of revenue, the global market size will reach US$ XX million by 2025.
This report presents a comprehensive overview, market shares, and growth opportunities of Procaine market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the Procaine, covering the supply chain analysis, impact assessment to the Procaine market size growth rate in several scenarios, and the measures to be undertaken by Procaine companies in response to the COVID-19 epidemic.
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Injection
Powder
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Hospital
Drug Store
On-line
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Eli Lilly and Company
Tbilchempharma
Consolidated Pharmaceutical
Bristol-Myers Squibb
Bel Mar Laboratories
Pfizer
Watson Laboratories
Elkins Sinn
RNP Pharmaceuticals
Bayer
Ardeapharma
Fuso Pharmaceutical
Stada
SÜDmedica Gmbh
Hikari Seiyaku
Towa Yakuhin
Teofarma
Köhler-Pharma
Grindeks
Hevert-Arzneimittel
Richter Pharma
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Procaine consumption (value & volume) by key regions/countries, type and access channel, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Procaine market by identifying its various subsegments.
Focuses on the key global Procaine manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Procaine with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Procaine submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 What is the Impact of Covid-19 Outbreak On the Procaine?
1.8.1 Optimistic Scenario: COVID-19 Is Contained by May or June, with Normalcy Returning to Global Operations Through the End of Q2.
1.8.2 Conservative Scenario: COVID-19 Remains Prevalent, with Continued Impacts Lasting Into Q4.
1.8.3 Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Global Procaine Market Size in 2020, by Scenario
1.8.4 Corporate Strategy the Manufacturers Should Be Thinking About Right Now
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Procaine Consumption 2015-2025
2.1.2 Procaine Consumption CAGR by Region
2.2 Procaine Segment by Type
2.2.1 Injection
2.2.2 Powder
2.3 Procaine Consumption by Type
2.3.1 Global Procaine Consumption Market Share by Type (2015-2020)
2.3.2 Global Procaine Revenue and Market Share by Type (2015-2020)
2.3.3 Global Procaine Sale Price by Type (2015-2020)
2.4 Procaine Segment by Access Channel
2.4.1 Hospital
2.4.2 Drug Store
2.4.3 On-line
2.5 Procaine Consumption by Access Channel
2.5.1 Global Procaine Consumption Market Share by Type (2015-2020)
2.5.2 Global Procaine Value and Market Share by Type (2015-2020)
2.5.3 Global Procaine Sale Price by Type (2015-2020)
3 Global Procaine by Company
3.1 Global Procaine Sales Market Share by Company
3.1.1 Global Procaine Sales by Company (2018-2020)
3.1.2 Global Procaine Sales Market Share by Company (2018-2020)
3.2 Global Procaine Revenue Market Share by Company
3.2.1 Global Procaine Revenue by Company (2018-2020)
3.2.2 Global Procaine Revenue Market Share by Company (2018-2020)
3.3 Global Procaine Sale Price by Company
3.4 Global Procaine Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Procaine Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Procaine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Procaine by Regions
4.1 Procaine by Regions
4.2 Americas Procaine Consumption Growth
4.3 APAC Procaine Consumption Growth
4.4 Europe Procaine Consumption Growth
4.5 Middle East & Africa Procaine Consumption Growth
5 Americas
5.1 Americas Procaine Consumption by Countries
5.1.1 Americas Procaine Consumption by Countries (2015-2020)
5.1.2 Americas Procaine Value by Countries (2015-2020)
5.2 Americas Procaine Consumption by Type
5.3 Americas Procaine Consumption by Access Channel
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Procaine Consumption by Regions
6.1.1 APAC Procaine Consumption by Regions (2015-2020)
6.1.2 APAC Procaine Value by Regions (2015-2020)
6.2 APAC Procaine Consumption by Type
6.3 APAC Procaine Consumption by Access Channel
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Procaine by Countries
7.1.1 Europe Procaine Consumption by Countries (2015-2020)
7.1.2 Europe Procaine Value by Countries (2015-2020)
7.2 Europe Procaine Consumption by Type
7.3 Europe Procaine Consumption by Access Channel
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Procaine by Countries
8.1.1 Middle East & Africa Procaine Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Procaine Value by Countries (2015-2020)
8.2 Middle East & Africa Procaine Consumption by Type
8.3 Middle East & Africa Procaine Consumption by Access Channel
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Procaine Distributors
10.3 Procaine Customer
11 Global Procaine Market Forecast
11.1 Global Procaine Consumption Forecast (2021-2025)
11.2 Global Procaine Forecast by Regions
11.2.1 Global Procaine Forecast by Regions (2021-2025)
11.2.2 Global Procaine Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Procaine Forecast by Type
11.8 Global Procaine Forecast by Access Channel
12 Key Players Analysis
12.1 Eli Lilly and Company
12.1.1 Company Information
12.1.2 Procaine Product Offered
12.1.3 Eli Lilly and Company Procaine Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Eli Lilly and Company Latest Developments
12.2 Tbilchempharma
12.2.1 Company Information
12.2.2 Procaine Product Offered
12.2.3 Tbilchempharma Procaine Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Tbilchempharma Latest Developments
12.3 Consolidated Pharmaceutical
12.3.1 Company Information
12.3.2 Procaine Product Offered
12.3.3 Consolidated Pharmaceutical Procaine Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Consolidated Pharmaceutical Latest Developments
12.4 Bristol-Myers Squibb
12.4.1 Company Information
12.4.2 Procaine Product Offered
12.4.3 Bristol-Myers Squibb Procaine Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Bristol-Myers Squibb Latest Developments
12.5 Bel Mar Laboratories
12.5.1 Company Information
12.5.2 Procaine Product Offered
12.5.3 Bel Mar Laboratories Procaine Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Bel Mar Laboratories Latest Developments
12.6 Pfizer
12.6.1 Company Information
12.6.2 Procaine Product Offered
12.6.3 Pfizer Procaine Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Pfizer Latest Developments
12.7 Watson Laboratories
12.7.1 Company Information
12.7.2 Procaine Product Offered
12.7.3 Watson Laboratories Procaine Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Watson Laboratories Latest Developments
12.8 Elkins Sinn
12.8.1 Company Information
12.8.2 Procaine Product Offered
12.8.3 Elkins Sinn Procaine Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Elkins Sinn Latest Developments
12.9 RNP Pharmaceuticals
12.9.1 Company Information
12.9.2 Procaine Product Offered
12.9.3 RNP Pharmaceuticals Procaine Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 RNP Pharmaceuticals Latest Developments
12.10 Bayer
12.10.1 Company Information
12.10.2 Procaine Product Offered
12.10.3 Bayer Procaine Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 Bayer Latest Developments
12.11 Ardeapharma
12.11.1 Company Information
12.11.2 Procaine Product Offered
12.11.3 Ardeapharma Procaine Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 Ardeapharma Latest Developments
12.12 Fuso Pharmaceutical
12.12.1 Company Information
12.12.2 Procaine Product Offered
12.12.3 Fuso Pharmaceutical Procaine Sales, Revenue, Price and Gross Margin (2018-2020)
12.12.4 Main Business Overview
12.12.5 Fuso Pharmaceutical Latest Developments
12.13 Stada
12.13.1 Company Information
12.13.2 Procaine Product Offered
12.13.3 Stada Procaine Sales, Revenue, Price and Gross Margin (2018-2020)
12.13.4 Main Business Overview
12.13.5 Stada Latest Developments
12.14 SÜDmedica Gmbh
12.14.1 Company Information
12.14.2 Procaine Product Offered
12.14.3 SÜDmedica Gmbh Procaine Sales, Revenue, Price and Gross Margin (2018-2020)
12.14.4 Main Business Overview
12.14.5 SÜDmedica Gmbh Latest Developments
12.15 Hikari Seiyaku
12.15.1 Company Information
12.15.2 Procaine Product Offered
12.15.3 Hikari Seiyaku Procaine Sales, Revenue, Price and Gross Margin (2018-2020)
12.15.4 Main Business Overview
12.15.5 Hikari Seiyaku Latest Developments
12.16 Towa Yakuhin
12.16.1 Company Information
12.16.2 Procaine Product Offered
12.16.3 Towa Yakuhin Procaine Sales, Revenue, Price and Gross Margin (2018-2020)
12.16.4 Main Business Overview
12.16.5 Towa Yakuhin Latest Developments
12.17 Teofarma
12.17.1 Company Information
12.17.2 Procaine Product Offered
12.17.3 Teofarma Procaine Sales, Revenue, Price and Gross Margin (2018-2020)
12.17.4 Main Business Overview
12.17.5 Teofarma Latest Developments
12.18 Köhler-Pharma
12.18.1 Company Information
12.18.2 Procaine Product Offered
12.18.3 Köhler-Pharma Procaine Sales, Revenue, Price and Gross Margin (2018-2020)
12.18.4 Main Business Overview
12.18.5 Köhler-Pharma Latest Developments
12.19 Grindeks
12.19.1 Company Information
12.19.2 Procaine Product Offered
12.19.3 Grindeks Procaine Sales, Revenue, Price and Gross Margin (2018-2020)
12.19.4 Main Business Overview
12.19.5 Grindeks Latest Developments
12.20 Hevert-Arzneimittel
12.20.1 Company Information
12.20.2 Procaine Product Offered
12.20.3 Hevert-Arzneimittel Procaine Sales, Revenue, Price and Gross Margin (2018-2020)
12.20.4 Main Business Overview
12.20.5 Hevert-Arzneimittel Latest Developments
12.21 Richter Pharma
12.21.1 Company Information
12.21.2 Procaine Product Offered
12.21.3 Richter Pharma Procaine Sales, Revenue, Price and Gross Margin (2018-2020)
12.21.4 Main Business Overview
12.21.5 Richter Pharma Latest Developments
13 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Global Procaine Market Size in 2020, by Scenario
Table 2. COVID-19: Measures to be Undertaken by Procaine Companies
Table 3. Research Methodology
Table 4. Data Source
Table 5. Procaine Consumption CAGR by Region 2015-2025 ($ Millions)
Table 6. Major Players of Injection
Table 7. Major Players of Powder
Table 8. Global Consumption Sales by Type (2015-2020)
Table 9. Global Procaine Consumption Market Share by Type (2015-2020)
Table 10. Global Procaine Revenue by Type (2015-2020) ($ million)
Table 11. Global Procaine Value Market Share by Type (2015-2020) ($ Millions)
Table 12. Global Procaine Sale Price by Type (2015-2020)
Table 13. Global Consumption Sales by Access Channel (2015-2020)
Table 14. Global Procaine Consumption Market Share by Access Channel (2015-2020)
Table 15. Global Procaine Value by Access Channel (2015-2020)
Table 16. Global Procaine Value Market Share by Access Channel (2015-2020)
Table 17. Global Procaine Sale Price by Access Channel (2015-2020)
Table 18. Global Procaine Sales by Company (2017-2019) (K Units)
Table 19. Global Procaine Sales Market Share by Company (2017-2019)
Table 20. Global Procaine Revenue by Company (2017-2019) ($ Millions)
Table 21. Global Procaine Revenue Market Share by Company (2017-2019)
Table 22. Global Procaine Sale Price by Company (2017-2019)
Table 23. Global Procaine Manufacturing Base Distribution and Sales Area by Manufacturers
Table 24. Players Procaine Products Offered
Table 25. Procaine Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 26. Global Procaine Consumption by Regions 2015-2020 (K Units)
Table 27. Global Procaine Consumption Market Share by Regions 2015-2020
Table 28. Global Procaine Value by Regions 2015-2020 ($ Millions)
Table 29. Global Procaine Value Market Share by Regions 2015-2020
Table 30. Americas Procaine Consumption by Countries (2015-2020) (K Units)
Table 31. Americas Procaine Consumption Market Share by Countries (2015-2020)
Table 32. Americas Procaine Value by Countries (2015-2020) ($ Millions)
Table 33. Americas Procaine Value Market Share by Countries (2015-2020)
Table 34. Americas Procaine Consumption by Type (2015-2020) (K Units)
Table 35. Americas Procaine Consumption Market Share by Type (2015-2020)
Table 36. Americas Procaine Consumption by Access Channel (2015-2020) (K Units)
Table 37. Americas Procaine Consumption Market Share by Access Channel (2015-2020)
Table 38. APAC Procaine Consumption by Countries (2015-2020) (K Units)
Table 39. APAC Procaine Consumption Market Share by Countries (2015-2020)
Table 40. APAC Procaine Value by Regions (2015-2020) ($ Millions)
Table 41. APAC Procaine Value Market Share by Regions (2015-2020)
Table 42. APAC Procaine Consumption by Type (2015-2020) (K Units)
Table 43. APAC Procaine Consumption Market Share by Type (2015-2020)
Table 44. APAC Procaine Consumption by Access Channel (2015-2020) (K Units)
Table 45. APAC Procaine Consumption Market Share by Access Channel (2015-2020)
Table 46. Europe Procaine Consumption by Countries (2015-2020) (K Units)
Table 47. Europe Procaine Consumption Market Share by Countries (2015-2020)
Table 48. Europe Procaine Value by Countries (2015-2020) ($ Millions)
Table 49. Europe Procaine Value Market Share by Countries (2015-2020)
Table 50. Europe Procaine Consumption by Type (2015-2020) (K Units)
Table 51. Europe Procaine Consumption Market Share by Type (2015-2020)
Table 52. Europe Procaine Consumption by Access Channel (2015-2020) (K Units)
Table 53. Europe Procaine Consumption Market Share by Access Channel (2015-2020)
Table 54. Middle East & Africa Procaine Consumption by Countries (2015-2020) (K Units)
Table 55. Middle East & Africa Procaine Consumption Market Share by Countries (2015-2020)
Table 56. Middle East & Africa Procaine Value by Countries (2015-2020) ($ Millions)
Table 57. Middle East & Africa Procaine Value Market Share by Countries (2015-2020)
Table 58. Middle East & Africa Procaine Consumption by Type (2015-2020) (K Units)
Table 59. Middle East & Africa Procaine Consumption Market Share by Type (2015-2020)
Table 60. Middle East & Africa Procaine Consumption by Access Channel (2015-2020) (K Units)
Table 61. Middle East & Africa Procaine Consumption Market Share by Access Channel (2015-2020)
Table 62. Procaine Distributors List
Table 63. Procaine Customer List
Table 64. Global Procaine Consumption Forecast by Countries (2021-2025) (K Units)
Table 65. Global Procaine Consumption Market Forecast by Regions
Table 66. Global Procaine Value Forecast by Countries (2021-2025) ($ Millions)
Table 67. Global Procaine Value Market Share Forecast by Regions
Table 68. Global Procaine Consumption Forecast by Type (2021-2025) (K Units)
Table 69. Global Procaine Consumption Market Share Forecast by Type (2021-2025)
Table 70. Global Procaine Value Forecast by Type (2021-2025) ($ Millions)
Table 71. Global Procaine Value Market Share Forecast by Type (2021-2025)
Table 72. Global Procaine Consumption Forecast by Access Channel (2021-2025) (K Units)
Table 73. Global Procaine Consumption Market Share Forecast by Access Channel (2021-2025)
Table 74. Global Procaine Value Forecast by Access Channel (2021-2025) ($ Millions)
Table 75. Global Procaine Value Market Share Forecast by Access Channel (2021-2025)
Table 76. Eli Lilly and Company Product Offered
Table 77. Eli Lilly and Company Procaine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 78. Eli Lilly and Company Main Business
Table 79. Eli Lilly and Company Latest Developments
Table 80. Eli Lilly and Company Basic Information, Company Total Revenue (in $ million), Procaine Manufacturing Base, Sales Area and Its Competitors
Table 81. Tbilchempharma Product Offered
Table 82. Tbilchempharma Procaine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 83. Tbilchempharma Main Business
Table 84. Tbilchempharma Latest Developments
Table 85. Tbilchempharma Basic Information, Company Total Revenue (in $ million), Procaine Manufacturing Base, Sales Area and Its Competitors
Table 86. Consolidated Pharmaceutical Product Offered
Table 87. Consolidated Pharmaceutical Procaine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 88. Consolidated Pharmaceutical Main Business
Table 89. Consolidated Pharmaceutical Latest Developments
Table 90. Consolidated Pharmaceutical Basic Information, Company Total Revenue (in $ million), Procaine Manufacturing Base, Sales Area and Its Competitors
Table 91. Bristol-Myers Squibb Product Offered
Table 92. Bristol-Myers Squibb Procaine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 93. Bristol-Myers Squibb Main Business
Table 94. Bristol-Myers Squibb Latest Developments
Table 95. Bristol-Myers Squibb Basic Information, Company Total Revenue (in $ million), Procaine Manufacturing Base, Sales Area and Its Competitors
Table 96. Bel Mar Laboratories Product Offered
Table 97. Bel Mar Laboratories Procaine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 98. Bel Mar Laboratories Main Business
Table 99. Bel Mar Laboratories Latest Developments
Table 100. Bel Mar Laboratories Basic Information, Company Total Revenue (in $ million), Procaine Manufacturing Base, Sales Area and Its Competitors
Table 101. Pfizer Product Offered
Table 102. Pfizer Procaine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 103. Pfizer Main Business
Table 104. Pfizer Latest Developments
Table 105. Pfizer Basic Information, Company Total Revenue (in $ million), Procaine Manufacturing Base, Sales Area and Its Competitors
Table 106. Watson Laboratories Product Offered
Table 107. Watson Laboratories Basic Information, Company Total Revenue (in $ million), Procaine Manufacturing Base, Sales Area and Its Competitors
Table 108. Watson Laboratories Main Business
Table 109. Watson Laboratories Latest Developments
Table 110. Watson Laboratories Procaine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 111. Elkins Sinn Product Offered
Table 112. Elkins Sinn Procaine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 113. Elkins Sinn Main Business
Table 114. Elkins Sinn Latest Developments
Table 115. Elkins Sinn Basic Information, Company Total Revenue (in $ million), Procaine Manufacturing Base, Sales Area and Its Competitors
Table 116. RNP Pharmaceuticals Product Offered
Table 117. RNP Pharmaceuticals Procaine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 118. RNP Pharmaceuticals Main Business
Table 119. RNP Pharmaceuticals Latest Developments
Table 120. RNP Pharmaceuticals Basic Information, Company Total Revenue (in $ million), Procaine Manufacturing Base, Sales Area and Its Competitors
Table 121. Bayer Product Offered
Table 122. Bayer Procaine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 123. Bayer Main Business
Table 124. Bayer Latest Developments
Table 125. Bayer Basic Information, Company Total Revenue (in $ million), Procaine Manufacturing Base, Sales Area and Its Competitors
Table 126. Ardeapharma Product Offered
Table 127. Ardeapharma Procaine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 128. Ardeapharma Main Business
Table 129. Ardeapharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 130. Ardeapharma Latest Developments
Table 131. Fuso Pharmaceutical Product Offered
Table 132. Fuso Pharmaceutical Procaine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 133. Fuso Pharmaceutical Main Business
Table 134. Fuso Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 135. Fuso Pharmaceutical Latest Developments
Table 136. Stada Product Offered
Table 137. Stada Procaine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 138. Stada Main Business
Table 139. Stada Latest Developments
Table 140. Stada Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 141. SÜDmedica Gmbh Product Offered
Table 142. SÜDmedica Gmbh Procaine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 143. SÜDmedica Gmbh Main Business
Table 144. SÜDmedica Gmbh Latest Developments
Table 145. SÜDmedica Gmbh Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 146. Hikari Seiyaku Product Offered
Table 147. Hikari Seiyaku Procaine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 148. Hikari Seiyaku Main Business
Table 149. Hikari Seiyaku Latest Developments
Table 150. Hikari Seiyaku Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 151. Towa Yakuhin Product Offered
Table 152. Towa Yakuhin Procaine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 153. Towa Yakuhin Main Business
Table 154. Towa Yakuhin Latest Developments
Table 155. Towa Yakuhin Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 156. Teofarma Product Offered
Table 157. Teofarma Procaine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 158. Teofarma Main Business
Table 159. Teofarma Latest Developments
Table 160. Teofarma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 161. Köhler-Pharma Product Offered
Table 162. Köhler-Pharma Procaine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 163. Köhler-Pharma Main Business
Table 164. Köhler-Pharma Latest Developments
Table 165. Köhler-Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 166. Grindeks Product Offered
Table 167. Grindeks Procaine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 168. Grindeks Main Business
Table 169. Grindeks Latest Developments
Table 170. Grindeks Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 171. Hevert-Arzneimittel Product Offered
Table 172. Hevert-Arzneimittel Procaine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 173. Hevert-Arzneimittel Main Business
Table 174. Hevert-Arzneimittel Latest Developments
Table 175. Hevert-Arzneimittel Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 176. Richter Pharma Product Offered
Table 177. Richter Pharma Procaine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 178. Richter Pharma Main Business
Table 179. Richter Pharma Latest Developments
Table 180. Richter Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
List of Figures
Figure 1. Picture of Procaine
Figure 2. Procaine Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Procaine Consumption Growth Rate 2015-2025 (K Units)
Figure 5. Global Procaine Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Injection
Figure 7. Product Picture of Powder
Figure 8. Global Procaine Consumption Market Share by Type (2015-2020)
Figure 9. Global Procaine Value Market Share by Type (2015-2020)
Figure 10. Procaine Consumed in Hospital
Figure 11. Global Procaine Market: Hospital (2015-2020) (K Units)
Figure 12. Global Procaine Market: Hospital (2015-2020) ($ Millions)
Figure 13. Procaine Consumed in Drug Store
Figure 14. Global Procaine Market: Drug Store (2015-2020) (K Units)
Figure 15. Global Procaine Market: Drug Store (2015-2020) ($ Millions)
Figure 16. Procaine Consumed in On-line
Figure 17. Global Procaine Market: On-line (2015-2020) (K Units)
Figure 18. Global Procaine Market: On-line (2015-2020) ($ Millions)
Figure 19. Global Procaine Consumption Market Share by Access Channel (2015-2020)
Figure 20. Global Procaine Value Market Share by Access Channel (2015-2020)
Figure 21. Global Procaine Sales Market Share by Company in 2017
Figure 22. Global Procaine Sales Market Share by Company in 2019
Figure 23. Global Procaine Revenue Market Share by Company in 2017
Figure 24. Global Procaine Revenue Market Share by Company in 2019
Figure 25. Global Procaine Sale Price by Company in 2019
Figure 26. Global Procaine Consumption Market Share by Regions 2015-2020
Figure 27. Global Procaine Value Market Share by Regions 2015-2020
Figure 28. Americas Procaine Consumption 2015-2020 (K Units)
Figure 29. Americas Procaine Value 2015-2020 ($ Millions)
Figure 30. APAC Procaine Consumption 2015-2020 (K Units)
Figure 31. APAC Procaine Value 2015-2020 ($ Millions)
Figure 32. Europe Procaine Consumption 2015-2020 (K Units)
Figure 33. Europe Procaine Value 2015-2020 ($ Millions)
Figure 34. Middle East & Africa Procaine Consumption 2015-2020 (K Units)
Figure 35. Middle East & Africa Procaine Value 2015-2020 ($ Millions)
Figure 36. Americas Procaine Consumption Market Share by Countries in 2019
Figure 37. Americas Procaine Value Market Share by Countries in 2019
Figure 38. Americas Procaine Consumption Market Share by Type in 2019
Figure 39. Americas Procaine Consumption Market Share by Access Channel in 2019
Figure 40. United States Procaine Consumption Growth 2015-2020 (K Units)
Figure 41. United States Procaine Value Growth 2015-2020 ($ Millions)
Figure 42. Canada Procaine Consumption Growth 2015-2020 (K Units)
Figure 43. Canada Procaine Value Growth 2015-2020 ($ Millions)
Figure 44. Mexico Procaine Consumption Growth 2015-2020 (K Units)
Figure 45. Mexico Procaine Value Growth 2015-2020 ($ Millions)
Figure 46. APAC Procaine Consumption Market Share by Countries in 2019
Figure 47. APAC Procaine Value Market Share by Regions in 2019
Figure 48. APAC Procaine Consumption Market Share by Type in 2019
Figure 49. APAC Procaine Consumption Market Share by Access Channel in 2019
Figure 50. China Procaine Consumption Growth 2015-2020 (K Units)
Figure 51. China Procaine Value Growth 2015-2020 ($ Millions)
Figure 52. Japan Procaine Consumption Growth 2015-2020 (K Units)
Figure 53. Japan Procaine Value Growth 2015-2020 ($ Millions)
Figure 54. Korea Procaine Consumption Growth 2015-2020 (K Units)
Figure 55. Korea Procaine Value Growth 2015-2020 ($ Millions)
Figure 56. Southeast Asia Procaine Consumption Growth 2015-2020 (K Units)
Figure 57. Southeast Asia Procaine Value Growth 2015-2020 ($ Millions)
Figure 58. India Procaine Consumption Growth 2015-2020 (K Units)
Figure 59. India Procaine Value Growth 2015-2020 ($ Millions)
Figure 60. Australia Procaine Consumption Growth 2015-2020 (K Units)
Figure 61. Australia Procaine Value Growth 2015-2020 ($ Millions)
Figure 62. Europe Procaine Consumption Market Share by Countries in 2019
Figure 63. Europe Procaine Value Market Share by Countries in 2019
Figure 64. Europe Procaine Consumption Market Share by Type in 2019
Figure 65. Europe Procaine Consumption Market Share by Access Channel in 2019
Figure 66. Germany Procaine Consumption Growth 2015-2020 (K Units)
Figure 67. Germany Procaine Value Growth 2015-2020 ($ Millions)
Figure 68. France Procaine Consumption Growth 2015-2020 (K Units)
Figure 69. France Procaine Value Growth 2015-2020 ($ Millions)
Figure 70. UK Procaine Consumption Growth 2015-2020 (K Units)
Figure 71. UK Procaine Value Growth 2015-2020 ($ Millions)
Figure 72. Italy Procaine Consumption Growth 2015-2020 (K Units)
Figure 73. Italy Procaine Value Growth 2015-2020 ($ Millions)
Figure 74. Russia Procaine Consumption Growth 2015-2020 (K Units)
Figure 75. Russia Procaine Value Growth 2015-2020 ($ Millions)
Figure 76. Middle East & Africa Procaine Consumption Market Share by Countries in 2019
Figure 77. Middle East & Africa Procaine Value Market Share by Countries in 2019
Figure 78. Middle East & Africa Procaine Consumption Market Share by Type in 2019
Figure 79. Middle East & Africa Procaine Consumption Market Share by Access Channel in 2019
Figure 80. Egypt Procaine Consumption Growth 2015-2020 (K Units)
Figure 81. Egypt Procaine Value Growth 2015-2020 ($ Millions)
Figure 82. South Africa Procaine Consumption Growth 2015-2020 (K Units)
Figure 83. South Africa Procaine Value Growth 2015-2020 ($ Millions)
Figure 84. Israel Procaine Consumption Growth 2015-2020 (K Units)
Figure 85. Israel Procaine Value Growth 2015-2020 ($ Millions)
Figure 86. Turkey Procaine Consumption Growth 2015-2020 (K Units)
Figure 87. Turkey Procaine Value Growth 2015-2020 ($ Millions)
Figure 88. GCC Countries Procaine Consumption Growth 2015-2020 (K Units)
Figure 89. GCC Countries Procaine Value Growth 2015-2020 ($ Millions)
Figure 90. Global Procaine Consumption Growth Rate Forecast (2021-2025) (K Units)
Figure 91. Global Procaine Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 92. Americas Procaine Consumption 2021-2025 (K Units)
Figure 93. Americas Procaine Value 2021-2025 ($ Millions)
Figure 94. APAC Procaine Consumption 2021-2025 (K Units)
Figure 95. APAC Procaine Value 2021-2025 ($ Millions)
Figure 96. Europe Procaine Consumption 2021-2025 (K Units)
Figure 97. Europe Procaine Value 2021-2025 ($ Millions)
Figure 98. Middle East & Africa Procaine Consumption 2021-2025 (K Units)
Figure 99. Middle East & Africa Procaine Value 2021-2025 ($ Millions)
Figure 100. United States Procaine Consumption 2021-2025 (K Units)
Figure 101. United States Procaine Value 2021-2025 ($ Millions)
Figure 102. Canada Procaine Consumption 2021-2025 (K Units)
Figure 103. Canada Procaine Value 2021-2025 ($ Millions)
Figure 104. Mexico Procaine Consumption 2021-2025 (K Units)
Figure 105. Mexico Procaine Value 2021-2025 ($ Millions)
Figure 106. Brazil Procaine Consumption 2021-2025 (K Units)
Figure 107. Brazil Procaine Value 2021-2025 ($ Millions)
Figure 108. China Procaine Consumption 2021-2025 (K Units)
Figure 109. China Procaine Value 2021-2025 ($ Millions)
Figure 110. Japan Procaine Consumption 2021-2025 (K Units)
Figure 111. Japan Procaine Value 2021-2025 ($ Millions)
Figure 112. Korea Procaine Consumption 2021-2025 (K Units)
Figure 113. Korea Procaine Value 2021-2025 ($ Millions)
Figure 114. Southeast Asia Procaine Consumption 2021-2025 (K Units)
Figure 115. Southeast Asia Procaine Value 2021-2025 ($ Millions)
Figure 116. India Procaine Consumption 2021-2025 (K Units)
Figure 117. India Procaine Value 2021-2025 ($ Millions)
Figure 118. Australia Procaine Consumption 2021-2025 (K Units)
Figure 119. Australia Procaine Value 2021-2025 ($ Millions)
Figure 120. Germany Procaine Consumption 2021-2025 (K Units)
Figure 121. Germany Procaine Value 2021-2025 ($ Millions)
Figure 122. France Procaine Consumption 2021-2025 (K Units)
Figure 123. France Procaine Value 2021-2025 ($ Millions)
Figure 124. UK Procaine Consumption 2021-2025 (K Units)
Figure 125. UK Procaine Value 2021-2025 ($ Millions)
Figure 126. Italy Procaine Consumption 2021-2025 (K Units)
Figure 127. Italy Procaine Value 2021-2025 ($ Millions)
Figure 128. Russia Procaine Consumption 2021-2025 (K Units)
Figure 129. Russia Procaine Value 2021-2025 ($ Millions)
Figure 130. Spain Procaine Consumption 2021-2025 (K Units)
Figure 131. Spain Procaine Value 2021-2025 ($ Millions)
Figure 132. Egypt Procaine Consumption 2021-2025 (K Units)
Figure 133. Egypt Procaine Value 2021-2025 ($ Millions)
Figure 134. South Africa Procaine Consumption 2021-2025 (K Units)
Figure 135. South Africa Procaine Value 2021-2025 ($ Millions)
Figure 136. Israel Procaine Consumption 2021-2025 (K Units)
Figure 137. Israel Procaine Value 2021-2025 ($ Millions)
Figure 138. Turkey Procaine Consumption 2021-2025 (K Units)
Figure 139. Turkey Procaine Value 2021-2025 ($ Millions)
Figure 140. GCC Countries Procaine Consumption 2021-2025 (K Units)
Figure 141. GCC Countries Procaine Value 2021-2025 ($ Millions)
Figure 142. Eli Lilly and Company Procaine Market Share (2018-2020)
Figure 143. Tbilchempharma Procaine Market Share (2018-2020)
Figure 144. Consolidated Pharmaceutical Procaine Market Share (2018-2020)
Figure 145. Bristol-Myers Squibb Procaine Market Share (2018-2020)
Figure 146. Bel Mar Laboratories Procaine Market Share (2018-2020)
Figure 147. Pfizer Procaine Market Share (2018-2020)
Figure 148. Watson Laboratories Procaine Market Share (2018-2020)
Figure 149. Elkins Sinn Procaine Market Share (2018-2020)
Figure 150. RNP Pharmaceuticals Procaine Market Share (2018-2020)
Figure 151. Bayer Procaine Market Share (2018-2020)
Figure 152. Ardeapharma Procaine Market Share (2018-2020)
Figure 153. Fuso Pharmaceutical Procaine Market Share (2018-2020)
Figure 154. Stada Procaine Market Share (2018-2020)
Figure 155. SÜDmedica Gmbh Procaine Market Share (2018-2020)
Figure 156. Hikari Seiyaku Procaine Market Share (2018-2020)
Figure 157. Towa Yakuhin Procaine Market Share (2018-2020)
Figure 158. Teofarma Procaine Market Share (2018-2020)
Figure 159. Köhler-Pharma Procaine Market Share (2018-2020)
Figure 160. Grindeks Procaine Market Share (2018-2020)
Figure 161. Hevert-Arzneimittel Procaine Market Share (2018-2020)
Figure 162. Richter Pharma Procaine Market Share (2018-2020)
Reason to Buy